Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Safer

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 8, 2022
More Data Against the Addition of Progestogens to Gender-Affirming Hormone Therapy RegimensJoshua D Safer
Molecular and Cellular Biochemistry|August 15, 2000
Sequestered actin in chick embryo fibroblastsK Nagamalleswari, D Safer
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 27, 2011
Graves disease and gynecomastia in 2 roommatesKaren Choong, Joshua D Safer
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 1, 1994
Beta thymosins as actin binding peptidesD Safer, V T Nachmias
Cell Reports. Medicine|January 18, 2023
The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapyMabel Yau, Joshua D Safer
Endocrine-Related Cancer|December 6, 2023
Gender-affirming care and endocrine-related cancersRoger Harty, Joshua D Safer
Clinics in Plastic Surgery|June 18, 2018
Hormone Therapy for Transgender MenSupraja Narasimhan, Joshua D Safer
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 1, 1994
Beta thymosins as actin binding peptidesD Safer, V T Nachmias
Clinical Pediatrics|May 1, 1989
Hyperactivity and inattentiveness. School assessment of stimulant treatmentD Safer, J M Krager
The Journal of Clinical Endocrinology and Metabolism|July 26, 2023
In a Modest Transgender Cohort Following Guidelines, Few Discontinued Treatment and Regret Was not ObservedMabel Yau, Joshua D Safer
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 8, 2022
More Data Against the Addition of Progestogens to Gender-Affirming Hormone Therapy RegimensJoshua D Safer
Molecular and Cellular Biochemistry|August 15, 2000
Sequestered actin in chick embryo fibroblastsK Nagamalleswari, D Safer
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 27, 2011
Graves disease and gynecomastia in 2 roommatesKaren Choong, Joshua D Safer
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 1, 1994
Beta thymosins as actin binding peptidesD Safer, V T Nachmias
Cell Reports. Medicine|January 18, 2023
The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapyMabel Yau, Joshua D Safer
Endocrine-Related Cancer|December 6, 2023
Gender-affirming care and endocrine-related cancersRoger Harty, Joshua D Safer
Clinics in Plastic Surgery|June 18, 2018
Hormone Therapy for Transgender MenSupraja Narasimhan, Joshua D Safer
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 1, 1994
Beta thymosins as actin binding peptidesD Safer, V T Nachmias
Clinical Pediatrics|May 1, 1989
Hyperactivity and inattentiveness. School assessment of stimulant treatmentD Safer, J M Krager
The Journal of Clinical Endocrinology and Metabolism|July 26, 2023
In a Modest Transgender Cohort Following Guidelines, Few Discontinued Treatment and Regret Was not ObservedMabel Yau, Joshua D Safer
Pageof 18